MicroRNA-592 Inhibits the Growth of Ovarian Cancer Cells by Targeting ERBB3

Objectives: Ovarian cancer is the most lethal gynecologic malignancy, and targeted therapy for different pathological types and molecular phenotypes is urgent to be studied. Studies have shown that MicroRNA-592 (miR-592) plays an important negative regulatory role in the occurrence of gastrointestin...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Qiong, Zhang, Ning, Zhan, Yang, Xu, Xiaohong, Han, Chao, Zhao, Hui, Hu, Xiaodi, Tang, Hongbo, Wu, Yumei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Novel Biomarkers, Molecular Diagnostics and Targeted Therapies of Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10021105/
https://www.ncbi.nlm.nih.gov/pubmed/36916303
http://dx.doi.org/10.1177/15330338231157156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10021105/
https://www.ncbi.nlm.nih.gov/pubmed/36916303
http://dx.doi.org/10.1177/15330338231157156

Ejemplares similares